ArcherDx, Inc., a leading player in the precision medicine industry, is headquartered in the United States, with significant operations across North America and Europe. Founded in 2013, the company has rapidly established itself as a pioneer in genomic profiling and next-generation sequencing technologies, focusing on oncology and rare diseases. ArcherDx is renowned for its innovative products, including the Archer FusionPlex and Archer VariantPlex assays, which enable comprehensive genomic analysis with unparalleled accuracy and sensitivity. These offerings are distinguished by their ability to detect a wide range of genetic alterations, making them invaluable tools for personalised cancer treatment. With a strong market position, ArcherDx has achieved notable milestones, including strategic partnerships and collaborations that enhance its research capabilities and expand its global reach. The company continues to drive advancements in molecular diagnostics, solidifying its reputation as a trusted leader in the field.
How does ArcherDx, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
ArcherDx, Inc.'s score of 23 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
ArcherDx, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that ArcherDx may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives at this time. As the company operates within a sector increasingly focused on sustainability, it may benefit from developing and communicating clear climate commitments to align with industry best practices.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
ArcherDx, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
